{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-2175-0026", "FDA", "FDA-2014-D-2175", "Reference 23 - Ebola Virus Can Be Effectively Neutralized by Antibody\nProduced in Natural Human Infection re Recommendations for Assessment of Blood Donor Suitability, Donor Deferral and Blood Product Management in Response to Ebola Virus; Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2015-12-07T05:00:00Z", 2015, 12, null, null, "2015-12-07T14:47:27Z", null, 0, 0, "0900006481d8915f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-2175-0026"], "units": {}, "query_ms": 0.3827969776466489, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}